Imai Hiroo 今井源

… Alternative Names

Hiroo Imai 今井源

Less

Researcher Number	80747585
Other IDs
Affiliation (Current)	2026: 東北大学, 大学病院, 助教
Affiliation (based on the past Project Information) *help	2022 – 2024: 東北大学, 大学病院, 助教
Review Section/Research Field	Principal Investigator Basic Section 50020:Tumor diagnostics and therapeutics-related
Keywords	Principal Investigator 抗がん剤 / メタボローム / マイクロビオーム / 抗癌剤 / 前向きⅡ相試験 / 抗菌薬 / 大腸がん / オキサリプラチン / NINJ2 / 腸内細菌 / 大腸癌

Development of Novel Cancer Therapies through Integrated Microbiome and Metabolome AnalysisPrincipal Investigator
- Principal Investigator
  
  Hiroo Imai
- Project Period (FY)
  2022 – 2024
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 50020:Tumor diagnostics and therapeutics-related
- Research Institution
  Tohoku University

All 2025 2024 2023

All Journal Article

[Journal Article] Influence of <i>Citrobacter freundii</i> on <i>NINJ2</i> Expression and Oxaliplatin Resistance in Colorectal Cancer2025
- Author(s)
  Ueta Reio, Hiroo Ima, Ken Saijo, Yoshifumi Kawamura, Chikashi Ishioka
- Journal Title
  
  Cancer Medicine
  
  Volume: in press
- Data Source
  KAKENHI-PROJECT-22K07293
[Journal Article] Chylous Ascites Associated with Advanced Pancreatic Cancer That Improved with Appropriate Treatment: A Case Report2024
- Author(s)
  Imai Hiroo、Saijo Ken、Takenaga Noriko、Komine Keigo、Ouchi Kota、Kasahara Yuki、Ishikawa Shiori、Sasaki Keiju、Yoshida Yuya、Shirota Hidekazu、Takahashi Masanobu、Ishioka Chikashi
- Journal Title
  
  Current Oncology
  
  Volume: 31 Issue: 3 Pages: 1477-1482
- DOI
  10.3390/curroncol31030112
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-22K07183, KAKENHI-PROJECT-22K07293
[Journal Article] Antibiotics May Interfere with Nivolumab Efficacy in Patients with Head and Neck Squamous Cell Carcinoma.2024
- Author(s)
  Ueta R, Imai H, Saijo K, Kawamura Y, Kodera S, Komine K, Ouchi K, Kasahara Y, Taniguchi S, Yoshida Y, Sasaki K, Shirota H, Takahashi M, Ishioka C.
- Journal Title
  
  Oncology.
  
  Volume: 102(3) Issue: 3 Pages: 252-259
- DOI
  10.1159/000533860
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-22K07183, KAKENHI-PROJECT-22K07293
[Journal Article] Pemigatinib in previously treated solid tumors with activating FGFR1-FGFR3 alterations: phase 2 FIGHT-207 basket trial2024
- Author(s)
  Rodon J, Damian S, Furqan M, Garcia-Donas J, Imai H, Italiano A, Spanggaard I, Ueno M, Yokota T, Veronese ML, Oliveira N, Li X, Gilmartin A, Schaffer M, Goyal L.
- Journal Title
  
  Nature Medicine
  
  Volume: 30（6）
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-22K07293
[Journal Article] Depth of response may predict clinical outcome in patients with recurrent/metastatic head and neck cancer treated with pembrolizumab-containing regimens.2023
- Author(s)
  Saijo K, Imai H, Ouchi K, Sasaki K, Yoshida Y, Kawamura Y, Taniguchi S, Kasahara Y, Komine K, Shirota H, Takahashi M, Ishioka C.
- Journal Title
  
  Front Oncol.
  
  Volume: 13 Issue: 5 Pages: 1230731-1230731
- DOI
  10.1159/000534747
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-22K07183, KAKENHI-PROJECT-22K07293

1. 城田英和

# of Collaborated Projects: 0 results

# of Collaborated Products: 3 results

Imai Hiroo 今井源

Hiroo Imai 今井源

Research Projects

Research Products

Co-Researchers

Development of Novel Cancer Therapies through Integrated Microbiome and Metabolome AnalysisPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

[Journal Article] Influence of <i>Citrobacter freundii</i> on <i>NINJ2</i> Expression and Oxaliplatin Resistance in Colorectal Cancer2025

Author(s)

Journal Title

Data Source

[Journal Article] Chylous Ascites Associated with Advanced Pancreatic Cancer That Improved with Appropriate Treatment: A Case Report2024

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Antibiotics May Interfere with Nivolumab Efficacy in Patients with Head and Neck Squamous Cell Carcinoma.2024

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Pemigatinib in previously treated solid tumors with activating FGFR1-FGFR3 alterations: phase 2 FIGHT-207 basket trial2024

Author(s)

Journal Title

Data Source

[Journal Article] Depth of response may predict clinical outcome in patients with recurrent/metastatic head and neck cancer treated with pembrolizumab-containing regimens.2023

Author(s)

Journal Title

DOI

Data Source

Imai Hiroo 今井 源

Hiroo Imai 今井 源

Research Projects

Research Products

Co-Researchers

Development of Novel Cancer Therapies through Integrated Microbiome and Metabolome AnalysisPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

[Journal Article] Influence of <i>Citrobacter freundii</i> on <i>NINJ2</i> Expression and Oxaliplatin Resistance in Colorectal Cancer2025

Author(s)

Journal Title

Data Source

[Journal Article] Chylous Ascites Associated with Advanced Pancreatic Cancer That Improved with Appropriate Treatment: A Case Report2024

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Antibiotics May Interfere with Nivolumab Efficacy in Patients with Head and Neck Squamous Cell Carcinoma.2024

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Pemigatinib in previously treated solid tumors with activating FGFR1-FGFR3 alterations: phase 2 FIGHT-207 basket trial2024

Author(s)

Journal Title

Data Source

[Journal Article] Depth of response may predict clinical outcome in patients with recurrent/metastatic head and neck cancer treated with pembrolizumab-containing regimens.2023

Author(s)

Journal Title

DOI

Data Source

Imai Hiroo 今井源

Hiroo Imai 今井源